Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.
about
Possible drug-drug interaction in dogs and cats resulted from alteration in drug metabolism: A mini reviewTherapeutic monitoring of vancomycin according to initial dosing regimen in pediatric patients.Prevalence of potential drug interactions in patients in an intensive care unit of a university hospital in BrazilDrug interactions in the hematopoietic stem cell transplant (HSCT) recipient: what every transplanter needs to know.Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents.Analysis of potential interactions between warfarin and prescriptions in Estonian outpatients aged 50 years or more.Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?Diagnosis and management for urosepsis.Role of therapeutic drug monitoring in pulmonary infections: use and potential for expanded use of dried blood spot samples.Predicting Clearance Mechanism in Drug Discovery: Extended Clearance Classification System (ECCS).Neuropsychiatric Effects of Antimicrobial Agents.Curcumin, Piperine, and Capsaicin: A Comparative Study of Spice-Mediated Inhibition of Human Cytochrome P450 Isozyme Activities.Disseminated Bartonella infection following liver transplantation.Acute colchicine intoxication during clarithromycin administration.Absence of pharmacokinetic interference of moxifloxacin on cyclosporine and tacrolimus in kidney transplant recipients.The NMR-derived solution structure of a new cationic antimicrobial peptide from the skin secretion of the anuran Hyla punctata.Synthesis of reduced xanthatin derivatives and in vitro evaluation of their antifungal activity.Development of an in vivo rat screen model to predict pharmacokinetic interactions of CYP3A4 substrates.Potential drug-drug interactions in cardiothoracic intensive care unit of a pulmonary teaching hospital.Interaction between warfarin and short-term intravenous amiodarone in intensive care unit patients after cardiac surgery.
P2860
Q26800015-942C9A43-253C-4FB5-91EB-DE8F10948E1BQ34494676-94E5170A-CD97-47CF-A849-7FBA6145221DQ34603864-ECF89F52-2D71-4381-B328-4F756AD9661BQ35608207-0238D38D-9A35-47A4-B270-C11E203F8EE2Q37157893-4102865D-76AA-4971-BD88-DF630BCCFEA7Q37233377-6D1A5438-319D-4434-AE47-3EFF373ED8A2Q37516599-AA2C2C3A-AB99-4D1D-BAAD-C33CA5F1C2B2Q38109961-C1336F3F-9E63-41BF-B628-FBF113AAF7F9Q38369608-0DDFAE94-8CEA-472B-A169-BB6378A4CE2CQ38855314-7ED96D3A-03AB-4CA6-B479-952AC794B03DQ39135986-1C70F9CA-D5E9-40EC-834D-3BD426741AA8Q39207677-42C95E9D-D0E4-4AD3-8183-EF4F877127AEQ40474968-130F6D43-CC8A-428D-B25E-692F0D9C7961Q40523203-6AE6CA1C-29F4-4EBB-B25D-9590ACCA6701Q43188224-83A73A41-5891-47C9-BB07-98290F272FA2Q44799164-CB9A6290-0131-4C6C-B9DC-8D6DEC714B30Q46891607-3B0CC84D-C94F-4512-AD6E-8366E9E43239Q46981409-0CB4C775-9CE4-45E0-B8E7-B9C53DEBCEBEQ51686250-392C4EBA-923B-4BC4-B779-AB9D5B89EAAAQ55129512-29A8AA9C-4AAA-4E08-B938-11432E84CD9F
P2860
Pharmacokinetic aspects of treating infections in the intensive care unit: focus on drug interactions.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Pharmacokinetic aspects of tre ...... t: focus on drug interactions.
@ast
Pharmacokinetic aspects of tre ...... t: focus on drug interactions.
@en
Pharmacokinetic aspects of tre ...... t: focus on drug interactions.
@nl
type
label
Pharmacokinetic aspects of tre ...... t: focus on drug interactions.
@ast
Pharmacokinetic aspects of tre ...... t: focus on drug interactions.
@en
Pharmacokinetic aspects of tre ...... t: focus on drug interactions.
@nl
prefLabel
Pharmacokinetic aspects of tre ...... t: focus on drug interactions.
@ast
Pharmacokinetic aspects of tre ...... t: focus on drug interactions.
@en
Pharmacokinetic aspects of tre ...... t: focus on drug interactions.
@nl
P2860
P1476
Pharmacokinetic aspects of tre ...... t: focus on drug interactions.
@en
P2093
P2860
P304
P356
10.2165/00003088-200140110-00004
P577
2001-01-01T00:00:00Z
P5875
P6179
1045609317